Clinical Laserthermia Systems (CLS) Americas said it has received its first order of the company's Tranberg thermal therapy system and accessories from the National Institutes of Health Clinical Center (NIHCC).
The order is about $80,000 and includes single-use sterile instruments that will be used to access the clinical use of the system for MRI/ultrasound fusion-guided focal laser ablation of prostate tissue and prostate cancer in male patients.
The contract falls under a research collaboration agreement between NIHCC and its Sweden-based parent company, Clinical Laserthermia Systems AB, the company said.
